DECLARATION OF CONFLICT OF INTEREST. None to declare
|
|
- Dayna Aubrie Franklin
- 6 years ago
- Views:
Transcription
1 DECLARATION OF CONFLICT OF INTEREST None to declare
2 Sympathetic nerve traffic, insulin resistance and baroreflex control of circulation in patients with resistant hypertension Gino Seravalle Marco Volpe Federica Ganz Laura Magni Gianmaria Brambilla Raffaella Dell Oro Simone Muraro Michele Bombelli Giuseppe Mancia Guido Grassi 572 GS European Society of Cardiology - Paris 2011
3 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G, Grassi G, HeagertyAM, Kjeldsen SE, Laurent S, Narkiewicz K, Ruilope L, Rynkiewicz A, Schmieder RE, StruijkerBoudier HA, Zanchetti A. J Hypertens 2007;25: Resistant hypertension: diagnosis, evaluation, and treatment. A scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD, White A, Cushman WC, White W, Sica D, Ferdinand K, Giles TD, Falkner B, Carey RM. Hypertension. 2008;51: Resistant hypertension is defined as the failure to achieve goal blood pressure in patients who are on optimal doses of three or more antihypertensive medications, ideally one of which is a diuretic 573 GS
4 Prevalence of TRUE resistant hypertension Prevalence of Resistant Hypertension in the United States, Stephen D. Persell Hypertension 2011; 57: The prevalence of resistant hypertension is unknown. Using data from the National Health and Nutrition Examination Survey from 2003 through 2008, nonpregnant adults with hypertension were classified as resistant if their blood pressure was 140/90 mm Hg and they reported using antihypertensive medications from 3 different drug classes or drugs from 4 antihypertensive drug classes regardless of blood pressure. Among US adults with hypertension, 8.9% (SE: 0.6%) met criteria for resistant hypertension. This represented 12.8% (SE: 0.9%) of the antihypertensive drug treated population. adults with resistant hypertension were more likely to be older, to be non- Hispanic black, and to have higher body mass index (all P<0.001). They were more likely to have albuminuria, reduced renal function, and self-reported medical histories of coronary heart disease, heart failure, stroke, and diabetes mellitus (P<0.001). Most (85.6% [SE: 2.4%]) individuals with resistant hypertension used a diuretic. Of this group, 64.4% (SE: 3.2%) used the relatively weak thiazide diuretic hydrochlorothiazide.. Cardiovascular diseases, diabetes mellitus, obesity, and renal dysfunction were all common in this population. 574 GS
5 Pathophysiological mechanisms in resistant hypertension Less nocturnal dipping Endothelial dysfunction Gene variations Insulin resistance Aldosterone 575 GS Yugar-Toledo JC et al DNACell Biol 2011 Mar 27; Quinaglia T et al J Human Hypertens, advanced publication May 2011 Pimenta E et al J Hypertens 2007;25:2131-7; Calhoun D et al Int J Hypertens 2011:837817
6 Aim of the study Aim of this study was to evaluate the neuroadrenergic profile and its relationship with metabolic/humoral patterns in patients with resistant hypertension 576 GS
7 Methods Population 8 Resistant Hypertensives (RHT; 6 M/2 F; age 61.8 ± 2.9 yrs) 13 Essential Hypertensives (EHT; 9 M/4 F; age 59.7 ± 2.3 yrs) 9 Healthy subjects (C; 7 M/2 F; age 60.0 ± 2.4 yrs) Parameters OSA/sleepiness Berlin questionnaire, Epworth Sleepiness Scale anthropometric: weight, BMI, WC echocardiographic: LVMI, LVEF metabolic Fasting glycaemia e insulinemia HOMA index 24-h ambulatory BP monitoring Spacelabs not invasive beat-to-beat BP Finapres heart rate EKG respiration rate pneumotachograph plasma aldosterone RIA muscle sympathetic nerve traffic Baroreflex sensitivity microneurography, peroneal nerve i.v. infusion vasoactive drugs 577 GS
8 (kg/m 2 ) (b/min) (mmhg) Anthropometric and haemodynamic parameters BMI HR BP S D 15 C EHT RHT 50 C EHT RHT 60 C EHT RHT P < GS
9 (bs/min) (bs/100hb) Sympathetic nerve traffic MSNA MSNA C EHT RHT C EHT RHT 20 P < 0.05; P < GS
10 Question Which mechanisms are responsible for the adrenergic overdrive of resistant hypertension? 1. Aspecific 2. Humoral 3. Metabolic 4. Reflex 580 GS
11 Question: Which mechanisms are responsible for the adrenergic overdrive of resistant hypertension? 1. Aspecific Different degree of BP load Different degree of TOD P < GS
12 (mmhg) Question: Which mechanisms are responsible for the adrenergic overdrive of resistant hypertension? 1. Aspecific Different degree of BP load Different degree of TOD h Daytime Night-time 150 S D 60 C EHT RHT C EHT RHT C EHT RHT P < GS
13 (mmhg) (g/m 2 ) Question: Which mechanisms are responsible for the adrenergic overdrive of resistant hypertension? 1. Aspecific Different degree of BP load Different degree of TOD h Daytime Night-time S LVMI D C EHT RHT C EHT RHT C EHT RHT 50 C EHT RHT P < GS
14 (ng/dl) Question: Which mechanisms are responsible for the adrenergic overdrive of resistant hypertension? 2. Humoral ALDO C EHT RHT P < GS
15 Question: Which mechanisms are responsible for the adrenergic overdrive of resistant hypertension? 3. Metabolic HOMA index C EHT RHT P < GS
16 Correlations between adrenergic and metabolic/humoral factors r Aldo vs MSNA 0.38 HOMA vs MSNA P < EHT RHT EHT RHT 584 GS
17 Question: Which mechanisms are responsible for the adrenergic overdrive of resistant hypertension? 4. Reflex 585 GS
18 Baroreflex Control of HR and MSNA in EHT and RHT HR (b/min) 9 MSNA (%i.a.) MAP (mmhg) <0.05 vs C C EHT RHT 1667 G
19 ΔMSNA (%i.a.)/δmap (mmhg) ΔHR (b/min)/δmap (mmhg) Question: Which mechanisms are responsible for the adrenergic overdrive of resistant hypertension? 4. Reflex Baroreflex sensitivity 0 C EHT RHT 0 C EHT RHT <0.05 vs C 585 GS
20 Conclusions These preliminary findings provide evidence that resistant hypertension is characterized by a marked sympathetic activation, greater for magnitude than that seen in non resistant essential hypertension. They also suggest that in resistant hypertension the adrenergic overdrive: - is not linked to sleep apnoea - is related to insulin resistance and to plasma aldosterone levels - is not influenced by reflex control mechanism that appears to be preserved Implication The greater sympathetic activation seen in resistant hypertension represents the pathophysiological background for the clinical use of renovascular denervation 586 GS
21
Declaration of conflict of interest
Declaration of conflict of interest Prevalence and main features of resistant hypertension in Central and Eastern Europe: data from the G. Brambilla 1, G. Seravalle 2, R. Cifkova 3, C. Farsang 4, S. Laurent
More informationThe role of physical activity in the prevention and management of hypertension and obesity
The 1 st World Congress on Controversies in Obesity, Diabetes and Hypertension (CODHy) Berlin, October 26-29 2005 The role of physical activity in the prevention and management of hypertension and obesity
More informationORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY. Introduction. Patients and Methods
Vol. 2, Issue 1, pages 31-36 ORIGINAL ARTICLE AMBULATORY BLOOD PRESSURE IN OBESITY By Alejandro de la Sierra, MD Luis M. Ruilope, MD Hypertension Units, Hospital Clinico, Barcelona & Hospital 12 de Octubre,
More informationΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH
ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH Hypertension Co-Morbidities HTN Commonly Clusters with Other Risk
More informationRegular physical exercise reduces blood pressure and is
Exercise in Resistant Hypertension Aerobic Exercise Reduces Blood Pressure in Resistant Hypertension Fernando Dimeo, Nikolaos Pagonas, Felix Seibert, Robert Arndt, Walter Zidek, Timm H. Westhoff Abstract
More informationInsulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults
Insulin resistance influences 24h heart rate and blood pressure variabilities and cardiovascular autonomic modulation in normotensive healthy adults Ochoa JE 1, Correa M 2, Valencia AM 2, Gallo J 2, McEwen
More informationThe Global SYMPLICITY Registry: Safety and Effectiveness of Renal Artery Denervation In Real World Patients With Uncontrolled Hypertension
The Global SYMPLICITY Registry: Safety and Effectiveness of Renal Artery Denervation In Real World Patients With Uncontrolled Hypertension Michael Böhm, MD on behalf of the GSR Investigators March 30,
More informationWhite-Coat and Masked Hypertension
White-Coat and Masked Hypertension Long-Term Risk of Sustained Hypertension in White-Coat or Masked Hypertension Giuseppe Mancia, Michele Bombelli, Rita Facchetti, Fabiana Madotto, Fosca Quarti-Trevano,
More informationCharacteristics and Future Cardiovascular Risk of Patients With Not-At- Goal Hypertension in General Practice in France: The AVANT AGE Study
ORIGINAL PAPER Characteristics and Future Cardiovascular Risk of Patients With Not-At- Goal Hypertension in General Practice in France: The AVANT AGE Study Yi Zhang, MD, PhD; 1 Helene Lelong, MD; 2 Sandrine
More informationCATHETER-BASED RENAL DENERVATION INCREASES INSULIN SENSITIVITY AND IMPROVES GLUCOSE METABOLISM IN PATIENTS WITH RESISTANT HYPERTENSION
CATHETER-BASED RENAL DENERVATION INCREASES INSULIN SENSITIVITY AND IMPROVES GLUCOSE METABOLISM IN PATIENTS WITH RESISTANT HYPERTENSION F. Mahfoud, Ch. Ukena, B. Cremers, I. Kindermann, M. Kindermann, P.
More informationReceived 24 February 2015 Revised 29 April 2015 Accepted 20 May 2015
Original article 1 Clinical practice of ambulatory versus home blood pressure monitoring in hypertensive patients Jorge A. Paolasso, Florencia Crespo, Viviana Arias, Eduardo A. Moreyra, Ariel Volmaro,
More informationObstructive sleep apnea (OSA) is considered an etiologic
Effects of Renal Sympathetic Denervation on Blood Pressure, Sleep Apnea Course, and Glycemic Control in Patients With Resistant Hypertension and Sleep Apnea Adam Witkowski, Aleksander Prejbisz, Elżbieta
More informationCARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES
CARDIOVASCULAR RISK FACTORS & TARGET ORGAN DAMAGE IN GREEK HYPERTENSIVES C. Liakos, 1 G. Vyssoulis, 1 E. Karpanou, 2 S-M. Kyvelou, 1 V. Tzamou, 1 A. Michaelides, 1 A. Triantafyllou, 1 P. Spanos, 1 C. Stefanadis
More informationDEPARTMENT OF GENERAL MEDICINE WELCOMES
DEPARTMENT OF GENERAL MEDICINE WELCOMES 1 Dr.Mohamed Omar Shariff, 2 nd Year Post Graduate, Department of General Medicine. DR.B.R.Ambedkar Medical College & Hospital. 2 INTRODUCTION Leading cause of global
More informationEvidence of Baroreflex Activation Therapy s Mechanism of Action
Evidence of Baroreflex Activation Therapy s Mechanism of Action Edoardo Gronda, MD, FESC Heart Failure Research Center IRCCS MultiMedica Cardiovascular Department Sesto S. Giovanni (Milano) Italy Agenda
More informationINCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS
INCREASED PULSE PRESSURE AND SYSTOLIC x HEART RATE DOUBLE PRODUCT AND CARDIOVASCULAR AUTONOMIC NEUROPATHY IN TYPE 2 DIABETIC PATIENTS A.J. Scheen, J.C. Philips, M. Marchand Division of Diabetes, Nutrition
More informationWhite coat hypertension, which
H Y P E R T E N S I O N A N D D I A B E T E S D E B A T E S Should White-Coat Hypertension in Diabetes Be Treated? Pro GIUSEPPE MANCIA, MD 1 ROBERTO SEGA, MD 1 MICHELE BOMBELLI, MD 1 White coat hypertension,
More informationValidation of the SEJOY BP-1307 upper arm blood pressure monitor for home. blood pressure monitoring according to the European Society of Hypertension
Validation of the SEJOY BP-1307 upper arm blood pressure monitor for home blood pressure monitoring according to the European Society of Hypertension International Protocol revision 2010 Short title: Validation
More informationJared Moore, MD, FACP
Hypertension 101 Jared Moore, MD, FACP Assistant Program Director, Internal Medicine Residency Clinical Assistant Professor of Internal Medicine Division of General Medicine The Ohio State University Wexner
More informationEffect of spironolactone in patients with resistant arterial hypertension in relation to age and sex: Insights from the aspirant trial
Effect of spironolactone in patients with resistant arterial hypertension in relation to age and sex: Insights from the aspirant trial Jan Vaclavik a, Richard Sedlak b, Jiri Jarkovsky c, Eva Kocianova
More informationThis article will focus on the role of the following in BP management and their prognostic significance:
CARDIOVASCULAR DISORDERS UNIT NO. 2 HOME BLOOD PRESSURE MONITORING, BLOOD PRESSURE VARIABILITY AND MORNING BLOOD PRESSURE SURGE Dr Rohit Khurana, Dr Lucy Priestner ABSTRACT Hypertension is a common chronic
More information4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?
HYPERTENSION TARGETS: WHAT DO WE DO NOW? MICHAEL LEFEVRE, MD, MSPH PROFESSOR AND VICE CHAIR DEPARTMENT OF FAMILY AND COMMUNITY MEDICINE UNIVERSITY OF MISSOURI 4/4/17 DISCLOSURE: MEMBER OF THE JNC 8 PANEL
More informationCardiovascular Disease Risk Factors and Blood Pressure Control in Ambulatory Care Visits to Physician Offices in the U.S.
Cardiovascular Disease Risk Factors and Blood Pressure Control in Ambulatory Care Visits to Physician Offices in the U.S. Item Type Thesis Authors Couch, Christopher Rights Copyright is held by the author.
More informationCombination Therapy for Hypertension
Combination Therapy for Hypertension Se-Joong Rim, MD Cardiology Division, Yonsei University College of Medicine, Seoul, Korea Goals of Therapy Reduce CVD and renal morbidity and mortality. Treat to BP
More informationRESISTENT HYPERTENSION. Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University
RESISTENT HYPERTENSION Dr. Helmy Bakr Professor and Head of Cardiology Dept. Mansoura University Resistant Hypertension Blood pressure remaining above goal in spite of concurrent use of 3 antihypertensive
More informationImportance of Ambulatory Blood Pressure Monitoring in Adolescents
Importance of Ambulatory Blood Pressure Monitoring in Adolescents Josep Redon, MD, PhD, FAHA Internal Medicine Hospital Clinico Universitario de Valencia University of Valencia CIBERObn Instituto de Salud
More informationEarly Detection of Damaged Organ
Early Detection of Damaged Organ Regional Cardiovascular Center, Chungbuk National University Kyung-Kuk Hwang Contents NICE guideline 2011 - Confirm the diagnosis of HT ambulatory blood pressure monitoring
More informationDIAGNOSIS AND TREATMENT OF RESISTANT HYPERTENSION: A REVIEW
DIAGNOSIS AND TREATMENT OF RESISTANT HYPERTENSION: A REVIEW Dr. Laxmi Narayan Goit 1* and Prof. Dr. Yang Shaning 2 1 Department of Cardiology, the first affiliated Hospital of Yangtze University, Jingzhou,
More informationProcess Measure: Screening for Adult Obstructive Sleep Apnea
Process Measure: Screening for Adult Obstructive Sleep Apnea Measure Description Description Type of Measure All patients aged 18 years and older at high risk for obstructive sleep apnea (OSA) with documentation
More informationNICE BHS Hypertension guidelines 2011 update
NICE BHS Hypertension guidelines 2011 update Review for clinicians Sept 2011 Mark Thomas West Midlands Hypertension Centre Heart of England NHS Trust www.wmhc.co.uk mark.thomas@heartofengland.nhs.uk Full
More informationReal World Experience with Renal Denervation Therapy
JCR 2013 Real World Experience with Renal Denervation Therapy Seung-Hyuk Choi Division of Cardiology Samsung Medical Center Seoul, Korea Hypertension A Major Public Health Burden Astonishing prevalence
More informationThe monthly ESH guide through publications
NEWSLETTER APRIL 2016 The monthly ESH guide through publications Edited by: Prof Costas Tsioufis, ESH Secretary and Dr Alex Kasiakogias Effects of hypertension treatment on heart failure: insights from
More informationCurrent strategies for managing hypertension
Eπίκαιρο Άρθρο Ambulatory blood pressure monitoring: the gold standard for the diagnosis and management of hypertension in general practice Eoin O Brien ABSTRACT Although ambulatory blood pressure measurement
More informationAssociation of 24 h systolic blood pressure variability and cardiovascular disease in patients with obstructive sleep apnea
Ke et al. BMC Cardiovascular Disorders (2017) 17:287 DOI 10.1186/s12872-017-0723-y RESEARCH ARTICLE Open Access Association of 24 h systolic blood pressure variability and cardiovascular disease in patients
More informationAmbulatory Blood Pressure Monitoring Clinical Practice Recommendations
Acta Medica Marisiensis 2016;62(3):350-355 DOI: 10.1515/amma-2016-0038 UPDATE Ambulatory Blood Pressure Monitoring Clinical Practice Recommendations Mako Katalin *, Ureche Corina, Jeremias Zsuzsanna University
More informationHypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents
Hypertension with Comorbidities Treatment of Metabolic Risk Factors in Children and Adolescents Stella Stabouli Ass. Professor Pediatrics 1 st Department of Pediatrics Hippocratio Hospital Evaluation of
More informationHypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital
Hypertension and obesity Dr Wilson Sugut Moi teaching and referral hospital No conflict of interests to declare Obesity Definition: excessive weight that may impair health BMI Categories Underweight BMI
More informationSympathetic Neural Mechanisms in White-Coat Hypertension
Journal of the American College of Cardiology Vol. 40, No. 1, 2002 2002 by the American College of Cardiology Foundation ISSN 0735-1097/02/$22.00 Published by Elsevier Science Inc. PII S0735-1097(02)01931-9
More informationBest Therapy for Resistant Hypertension: The PATHWAY-2 2 Study
Best Therapy for Resistant Hypertension: The PATHWAY-2 2 Study Antonio Coca MD, PhD, FRCP, FESC Council on Hypertension. European Society of Cardiology Hypertension and Vascular Risk Unit. Department of
More information가정혈압의활용 CARDIOVASCULAR CENTER. Wook Bum Pyun M.D., Ph.D. HOME BLOOD PRESSURE MONITORING. Ewha Womans University, school of Medicine
가정혈압의활용 HOME BLOOD PRESSURE MONITORING CARDIOVASCULAR CENTER Wook Bum Pyun M.D., Ph.D. pwb423@ewha.ac.kr Ewha Womans University, school of Medicine Non-Invasive Blood Pressure Measurement 5-20% Resistant
More informationEFFICACY & SAFETY OF ORAL TRIPLE DRUG COMBINATION OF TELMISARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF NON-DIABETIC HYPERTENSION
EFFICACY & SAFETY OF ORAL TRIPLE DRUG COMBINATION OF TELMISARTAN, AMLODIPINE AND HYDROCHLOROTHIAZIDE IN THE MANAGEMENT OF NON-DIABETIC HYPERTENSION Khemchandani D. 1 and * Arif A. Faruqui 2 1 Bairagarh,
More informationKnowledge and Implementation of the New European Guide in the Management of Arterial Hypertension. The Cigema Survey
Pharmaceuticals 2009, 2, 11-32; doi:10.3390/ph2020011 Article OPEN ACCESS Pharmaceuticals ISSN 1424-8247 www.mdpi.com/journal/pharmaceuticals Knowledge and Implementation of the New European Guide in the
More informationWhat We've Learned from Simplicity HTN-1,2, and Registries
ANGIOPLASTY SUMMIT-TCTAP 2012 Seoul, Korea, April 24-27, 2012 What We've Learned from Simplicity HTN-1,2, and Registries Horst Sievert, Ann-Kathrin Ziegler, Benjamin Kaltenbach, Ilona Hofmann, Undine Pittl
More informationHow clinically important are the results of the large trials in hypertension?
How clinically important are the results of the large trials in hypertension? Stéphane LAURENT, MD, PhD, FESC Pharmacology Department and PARCC / INSERM U970 Hôpital Européen Georges Pompidou, Université
More informationHypertension Update Warwick Jaffe Interventional Cardiologist Ascot Hospital
Hypertension Update 2008 Warwick Jaffe Interventional Cardiologist Ascot Hospital Definition of Hypertension Continuous variable At some point the risk becomes high enough to justify treatment Treatment
More informationHipertensión enmascarada. Alejandro de la Sierra Hospital Mútua Terrassa Universitat de Barcelona
Hipertensión enmascarada Alejandro de la Sierra Hospital Mútua Terrassa Universitat de Barcelona HTA enmascarada Definición Prevalencia Características clínicas Riesgo derivado Asociación con LOD Progresión
More informationTarget Blood Pressure in Patients with Diabetes: Asian Perspective
Review Article Yonsei Med J 2016 Nov;57(6):1307-1311 pissn: 0513-5796 eissn: 1976-2437 Target Blood Pressure in Patients with Diabetes: Asian Perspective Sungha Park 1, Kazuomi Kario 2, Chang-Gyu Park
More informationEffect of renal denervation on glucose metabolism after a 12 month follow-up
Effect of renal denervation on glucose metabolism after a 12 month follow-up Daniel Matous a, Otakar Jiravsky a, Igor Nykl a, Marian Branny a Background. Renal denervation is an invasive endovascular procedure
More informationTherapeutic Advances in Cardiovascular Disease
452190TAK641753944712452190H Punzi, A ShojaeeTherapeutic Advances in Cardiovascular Disease 2012 Therapeutic Advances in Cardiovascular Disease Original Research Efficacy and tolerability of fixed-dose
More informationHigh Risk OSA n = 5,359
Table S1 Prevalence of atrial fibrillation (AF) identified using different methods in participants with high and low risk obstructive sleep apnea (). High Risk n = 5,359 Low Risk n = 14,992 SR-AF (%) 467
More informationBlood Pressure Targets in Diabetes
Stockholm, 29 th August 2010 ESC Meeting Blood Pressure Targets in Diabetes Peter M Nilsson, MD, PhD Department of Clinical Sciences University Hospital, Malmö Sweden Studies on BP in DM2 ADVANCE RCT (Lancet
More informationDIFFERENTE RELAZIONE TRA VALORI PRESSORI E MASSA VENTRICOLARE SX NEI DUE SESSI IN PAZIENTI IPERTESI.
DIFFERENTE RELAZIONE TRA VALORI PRESSORI E MASSA VENTRICOLARE SX NEI DUE SESSI IN PAZIENTI IPERTESI. Franco Cipollini, Carlo Porta, Enrica Arcangeli, Carla Breschi, & Giuseppe Seghieri Azienda USL 3, Ambulatorio
More informationDifficult-to-Control & Resistant Hypertension. Anthony Viera, MD, MPH, FAHA Professor and Chair
Difficult-to-Control & Resistant Hypertension Anthony Viera, MD, MPH, FAHA Professor and Chair Objectives Define resistant hypertension Discuss evaluation strategy for patient with HTN that appears difficult
More informationIdentification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study
Identification of patients with heart failure and PREserved systolic Function : an Epidemiologic Regional study Dr. Antonio Magaña M.D. (on behalf I-PREFER investigators group) Stockholm, Sweden, August
More informationResistant Hypertension: Incidence, Prevalence and Prognosis
Resistant Hypertension: Incidence, Prevalence and Prognosis Running title: Pimenta et al.; Resistant hypertension Eduardo Pimenta, MD 1 and David A. Calhoun, MD 2 1 Endocrine Hypertension Rsrch Ctr & Clinical
More informationCatheter-Based Renal Denervation (RDN)
Hypertension lecture 3: Catheter-Based Renal Denervation (RDN) Adapted from slides prepared by Dr IOEBRAHIM, UNITAS HOSPITAL and others Hypertension Epidemiology 30% Untreated 35% Treated & Controlled
More informationObstructive sleep apnea syndrome as a cause of resistant hypertension
(2014) 37, 601 613 & 2014 The Japanese Society of Hypertension All rights reserved 0916-9636/14 www.nature.com/hr REVIEW SERIES Obstructive sleep apnea syndrome as a cause of resistant hypertension Gianfranco
More informationSlide notes: References:
1 2 3 Cut-off values for the definition of hypertension are systolic blood pressure (SBP) 135 and/or diastolic blood pressure (DBP) 85 mmhg for home blood pressure monitoring (HBPM) and daytime ambulatory
More informationRenal denervation: Current evidence and remaining uncertainties
Renal denervation: Current evidence and remaining uncertainties Michel Azizi Georges Pompidou European Hospital Hypertension Unit ESH excellence Center Paris Descartes University Clinical Investigation
More informationManagement of Hypertension and Consequences of non-compliance. Colin Edwards
Management of Hypertension and Consequences of non-compliance Colin Edwards CARDIOLOGIST AHG May 2016 Outline 1. Consequences of poorly controlled hypertension 2. BP targets and anti-hypertensive drugs
More informationAlthough it is well established that the sympathetic. The Sympathetic Nervous System and Long-Term Blood Pressure Regulation. Thomas E.
AJH 2001; 14:147S 154S The Sympathetic Nervous System and Long-Term Blood Pressure Regulation Thomas E. Lohmeier There is considerable evidence that activation of the sympathetic nervous system plays an
More informationThe effect of antihypertensive agents on sleep apnea: protocol for a randomized controlled trial
Cichelero et al. Trials 2014, 15:1 TRIALS STUDY PROTOCOL Open Access The effect of antihypertensive agents on sleep apnea: protocol for a randomized controlled trial Fábio Tremea Cichelero 1, Denis Martinez
More informationCatheter-Based Renal Denervation Reduces Total Body and Renal Noradrenaline Spillover and Blood Pressure in Resistant Hypertension
Catheter-Based Renal Denervation Reduces Total Body and Renal Noradrenaline Spillover and Blood Pressure in Resistant Hypertension Murray Esler, Markus Schlaich, Paul Sobotka, Rob Whitbourn, Jerzy Sadowski,
More informationDisclosures. Diabetes and Cardiovascular Risk Management. Learning Objectives. Atherosclerotic Cardiovascular Disease
Disclosures Diabetes and Cardiovascular Risk Management Tony Hampton, MD, MBA Medical Director Advocate Aurora Operating System Advocate Aurora Healthcare Downers Grove, IL No conflicts or disclosures
More informationΚέντρο Υπέρτασης STRIDE-7 Γ Παθολογική Κλινική Πανεπιστημίου Αθηνών Νοσοκομείο Σωτηρία. Υπέρταση και ΣΑΥ. ΓΣ Στεργίου
Κέντρο Υπέρτασης STRIDE-7 Γ Παθολογική Κλινική Πανεπιστημίου Αθηνών Νοσοκομείο Σωτηρία Υπέρταση και ΣΑΥ ΓΣ Στεργίου Search results Items: 4480 14/04/2016 1990 N=35 2000 N=106 2015 N=338 Pages 130 Ref:
More informationHypertension: What s new since JNC 7. Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF
Hypertension: What s new since JNC 7 Harold M. Szerlip, MD, FACP, FCCP, FASN, FNKF Disclosures Spectral Diagnostics Site investigator Eli Lilly Site investigator ACP IM ITE writing committee NBME Step
More informationHeart Failure and Sleep Disordered Breathing (SDB) Unhappy Bedfellows
Question Heart Failure and Sleep Disordered Breathing (SDB) Unhappy Bedfellows 1 ResMed 2012 07 2 ResMed 2012 07 Open Airway 3 ResMed 2012 07 Flow Limitation Snore 4 ResMed 2012 07 Apnoea 5 ResMed 2012
More informationOSA and cardiovascular disease what is the evidence? Mohan Edupuganti, MD, FACC. Baptist Health Cardiology. Disclosures: None
OSA and cardiovascular disease what is the evidence? Mohan Edupuganti, MD, FACC. Baptist Health Cardiology. Disclosures: None 1 OSA basics Affects 20-30% of males and 10-15% of females in North America
More informationStephen G. Worthley 1, Gerard T. Wilkins 2, Mark W. Webster 3,Joseph K. Montarello 1, Paul T. Antonis 4, Robert J. Whitbourn 5, Roderic J.
Six Month Results of First-in-Human Sympathetic Renal Artery Denervation Using a Next Generation Multi-Electrode Renal Artery Denervation System in Patients with Drug-Resistant Hypertension Stephen G.
More informationSome approaches to improving patients compliance with antihypertensive pharmacotherapy
Some approaches to improving patients compliance with antihypertensive pharmacotherapy Vdovichenko V., 1 * Snezhitskiy V., 2 Kazakiewicz D. 1 1 Pharmacology Department, Grodno State Medical University,
More informationOSA and Hypertension Scope of the Problem
OSA and Hypertension Scope of the Problem Dr Ahmad Izuanuddin Ismail Senior Lecturer & Respiratory Physician Faculty of Medicine, Universiti Teknologi MARA izuanuddin@salam.uitm.edu.my http://respiratoryuitm.com
More informationDiabetes & Obstructive Sleep Apnoea risk. Jaynie Pateraki MSc RGN
Diabetes & Obstructive Sleep Apnoea risk Jaynie Pateraki MSc RGN Non-REM - REM - Both - Unrelated - Common disorders of Sleep Sleep Walking Night terrors Periodic leg movements Sleep automatism Nightmares
More informationnoradrenaline spillover and systemic blood pressure in patients with resistant hypertension
Effects of renal sympathetic denervation on noradrenaline spillover and systemic blood pressure in patients with resistant hypertension Markus Schlaich Neurovascular Hypertension & Kidney Disease Laboratory
More informationNormal Ambulatory Blood Pressure: A Clinical-Practice- Based Analysis of Recent American Heart Association Recommendations
The American Journal of Medicine (2006) 119, 69.e13-69.e18 CLINICAL RESEARCH STUDY Normal Ambulatory Blood Pressure: A Clinical-Practice- Based Analysis of Recent American Heart Association Recommendations
More informationRelevance of sympathetic overactivity in hypertension and heart failure Therapeutic Implications
Relevance of sympathetic overactivity in hypertension and heart failure Therapeutic Implications Uta C. Hoppe, MD, FESC Dep. of Internal Medicine II Paracelsus University Salzburg Austria Disclosures Within
More informationPatrick Kay, General and Interventional Cardiologist Auckland or healthpoint.co.nz
Patrick Kay, General and Interventional Cardiologist Auckland ipatkay@hotmail.com or healthpoint.co.nz Rotorua 2015 Rotorua 2015 Graphical example of true mean and variation, and of regression to the
More information2007 Guidelines for the Management of Arterial Hypertension
Guidelines 1105 Guidelines 2007 Guidelines for the Management of Arterial Hypertension The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the
More informationDECLARATION OF CONFLICT OF INTEREST. None
DECLARATION OF CONFLICT OF INTEREST None How low should we go to avoid harm in hypertensives with comorbidities? CORONARY ARTERY DISEASE Prof. Dr. Maria DOROBANTU, FESC,FACC CARDIOLOGY EMERGENCY HOSPITAL
More informationApelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure
Apelin and Visfatin Plasma Levels in Healthy Individuals With High Normal Blood Pressure CI Liakos, 1 EA Sanidas, 1 DN Perrea, 1 V Gennimata, 1 V Chantziara, 1 CA Grassos, 2 N-A Viniou, 1 JD Barbetseas,
More informationJNC-8. (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure- 8) An Update on Hypertension Guidelines
JNC-8 (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure- 8) An Update on Hypertension Guidelines Derrick Sorweide, DO Assistant Professor of Family Medicine,
More informationSympathetic hyperactivity is known to occur in essential
Impact of Type 2 Diabetes Mellitus on Sympathetic Neural Mechanisms in Hypertension Robert J. Huggett, MB, BS; Eleanor M. Scott, BM, BS, MD; Stephen G. Gilbey, BA, MD; John B. Stoker, BSc, MB, ChB; Alan
More informationAdherence to Antihypertensive Medication in the older hypertensive patients: the role of blood pressure measurement assistance
Research Article Pharmaceutical Adherence to Antihypertensive Medication in the older hypertensive patients: the role of blood pressure measurement assistance Aim: To evaluate the compliance of patients
More informationAssociation between arterial stiffness and cardiovascular risk factors in a pediatric population
+ Association between arterial stiffness and cardiovascular risk factors in a pediatric population Maria Perticone Department of Experimental and Clinical Medicine University Magna Graecia of Catanzaro
More informationHow do we diagnose hypertension today? Presentation Subtitle
How do we diagnose hypertension today? Presentation Subtitle Renata Cífková Case 1 JM, a 64-year-old lady referred to our center because of undesirable effects of her antihypertensive medication Personal
More informationA fixed-dose combination of bisoprolol and amlodipine in daily practice treatment of hypertension: Results of a noninvestigational
Hostalek U et al. Medical Research Archives, vol. 5, issue 11, November 2017 issue Page 1 of 11 RESEARCH ARTICLE A fixed-dose combination of bisoprolol and amlodipine in daily practice treatment of hypertension:
More informationRISE, FALL AND RESURRECTION OF RENAL DENERVATION. Michael A. Weber, MD State University of New York Downstate College of Medicine
RISE, FALL AND RESURRECTION OF RENAL DENERVATION Michael A. Weber, MD State University of New York Downstate College of Medicine Michael Weber, Disclosures Research/Trial Commitments and Consulting: Boston
More informationDanno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo?
Danno d organo bersaglio e rischio CV. Persiste un ruolo prognostico oltre la patologia d organo? Prof. Massimo Salvetti Clinica Medica University of Brescia Percieved risk Actual risk Sehestedt et al,
More informationESH Position Paper: Renal denervation ^ an interventional therapy of resistant hypertension
ESH Statement ESH Position Paper: Renal denervation ^ an interventional therapy of resistant hypertension Roland E. Schmieder a, Josep Redon b, Guido Grassi c,k, Sverre E. Kjeldsen d, Giuseppe Mancia e,
More informationEfficacy and Safety of a Single-Pill Fixed-Dose Combination of Azilsartan and Amlodipine
Elmer ress Original Article J Clin Med Res. 2016;8(12):888-892 Efficacy and Safety of a Single-Pill Fixed-Dose Combination of Azilsartan and Amlodipine Kota Motozato a, b, Shin-ichiro Miura a, c, d, Yuhei
More informationSTATE OF THE ART BP ASSESSMENT
STATE OF THE ART BP ASSESSMENT PROFESSOR MOLECULAR PHARMACOLOGY CONWAY INSTITUE UNIVERSITY COLLEGE DUBLIN CO-CHAIRMAN BLOOD PRESCSURE MANAGEMENT IN LOW RESOURCE SETTINGS CENTRE FOR INTERNATIONAL HUMANITARIAN
More informationYuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China
What Can We Learn from the Observational Studies and Clinical Trials of Prehypertension? Yuqing Zhang, M.D., FESC Department of Cardiology, Fu Wai Hospital. CAMS & PUMC, Beijing, China At ARIC visit 4
More informationWhich antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017
Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017 The most important reason for treating hypertension in primary care is to prevent
More informationAGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK. Michael Smolensky, Ph.D. The University of Texas Austin & Houston
AGING, BLOOD PRESSURE & CARDIOVASCULAR DISEASE EVENT RISK Michael Smolensky, Ph.D. The University of Texas Austin & Houston Disclosures Partner: Circadian Ambulatory Diagnostics Consultant: Spot On Sciences
More informationThe Hypertension Clinic is a part of the Internal Medicine
Original Article Hypertension Registry at the Bangkok Hospital Medical Center: The First 7 Months Experience OBJECTIVE: The Hypertension Registry at the Bangkok Hospital Medical Center was established
More informationA Comparative Study of Physical Fitness among Rural Farmers and Urban Sedentary Group of Gulbarga District
AJMS Al Ameen J Med Sci (20 1 2 )5 (1 ):3 9-4 4 (A US National Library of Medicine enlisted journal) I S S N 0 9 7 4-1 1 4 3 C O D E N : A A J M B G ORIGI NAL ARTICLE A Comparative Study of Physical Fitness
More informationCorrelation of nocturnal blood pressure pattern with dysautonomia in hypertensive patients with orthostatic hypotension
Human & Veterinary Medicine International Journal of the Bioflux Society OPEN ACCESS Research Article Correlation of nocturnal blood pressure pattern with dysautonomia in hypertensive patients with orthostatic
More informationIn the Literature 1001 BP of 1.1 mm Hg). The trial was stopped early based on prespecified stopping rules because of a significant difference in cardi
Is Choice of Antihypertensive Agent Important in Improving Cardiovascular Outcomes in High-Risk Hypertensive Patients? Commentary on Jamerson K, Weber MA, Bakris GL, et al; ACCOMPLISH Trial Investigators.
More informationDetection of Atrial Fibrillation Using a Modified Microlife Blood Pressure Monitor
nature publishing group Detection of Atrial Fibrillation Using a Modified Microlife Blood Pressure Monitor Joseph Wiesel 1, Lorenzo Fitzig 1, Yehuda Herschman 2 and Frank C. Messineo 1 Background Hypertension
More informationHypertension And Diabetes
Hypertension And Diabetes 1 / 6 2 / 6 3 / 6 Hypertension And Diabetes Award Winning Diabetes And Hypertension Center is involved with latest technology and treatment in order to prevent decrease the incidence
More information